These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6427599

  • 1. Human placenta aldose reductase. Forms sensitive and insensitive to inhibition by alrestatin.
    Maragoudakis ME, Wasvary J, Hankin H, Gargiulo P.
    Mol Pharmacol; 1984 May; 25(3):425-30. PubMed ID: 6427599
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of human brain aldose reductase and hexonate dehydrogenase by alrestatin and sorbinil.
    O'Brien MM, Schofield PJ, Edwards MR.
    J Neurochem; 1982 Sep; 39(3):810-4. PubMed ID: 6808090
    [Abstract] [Full Text] [Related]

  • 4. Oxidized aldose reductase: in vivo factor not in vitro artifact.
    Grimshaw CE, Lai CJ.
    Arch Biochem Biophys; 1996 Mar 01; 327(1):89-97. PubMed ID: 8615700
    [Abstract] [Full Text] [Related]

  • 5. Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors.
    Srivastava SK, Petrash JM, Sadana IJ, Ansari NH, Partridge CA.
    Curr Eye Res; 1996 Mar 01; 2(6):407-10. PubMed ID: 6820339
    [Abstract] [Full Text] [Related]

  • 6. Inhibition kinetics of human kidney aldose and aldehyde reductases by aldose reductase inhibitors.
    Bhatnagar A, Liu SQ, Das B, Ansari NH, Srivastava SK.
    Biochem Pharmacol; 1990 Mar 15; 39(6):1115-24. PubMed ID: 2157439
    [Abstract] [Full Text] [Related]

  • 7. Activated and unactivated forms of human erythrocyte aldose reductase.
    Srivastava SK, Hair GA, Das B.
    Proc Natl Acad Sci U S A; 1985 Nov 15; 82(21):7222-6. PubMed ID: 3933003
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S, Kador PF.
    Biochem Pharmacol; 1990 Sep 01; 40(5):1033-42. PubMed ID: 2117925
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Mechanism of inhibition of aldose reductase by menadione (vitamin K3).
    Bhatnagar A, Liu SQ, Petrash JM, Srivastava SK.
    Mol Pharmacol; 1992 Nov 01; 42(5):917-21. PubMed ID: 1435755
    [Abstract] [Full Text] [Related]

  • 11. Aldose reductase inhibition by anti-allergy drugs.
    Kador PF, Sharpless NE, Goosey JD.
    Prog Clin Biol Res; 1982 Nov 01; 114():243-59. PubMed ID: 6131432
    [No Abstract] [Full Text] [Related]

  • 12. Placental aldose reductase inhibition by Silybin (preliminary communication).
    Santos J, Mira LB, Freire AM, Azevedo M, Manso C.
    Acta Med Port; 1984 Nov 01; 5(4-5):115-7. PubMed ID: 6431756
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Involvement of sulfhydryl residues in aldose reductase-inhibitor interaction.
    Bhatnagar A, Liu S, Das B, Srivastava SK.
    Mol Pharmacol; 1989 Dec 01; 36(6):825-30. PubMed ID: 2513474
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of alrestatin on arginine-induced secretion of glucagon and insulin in the rat.
    Lippmann W, Kobric M.
    Horm Metab Res; 1978 Jul 01; 10(4):280-2. PubMed ID: 98419
    [Abstract] [Full Text] [Related]

  • 17. Spectral properties of human placental aldose reductase and aldehyde reductase II.
    Das B, Bhatnagar A, Liu SQ, Srivastava SK, Messmer M, Ueno N, Chakrabarti B.
    Biochem Int; 1989 Sep 01; 19(3):497-504. PubMed ID: 2510724
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.